CorVel Q1 FY2027: Revenue Rises 11% to $260M, EPS Hits $0.63, $256M Cash with Zero Debt
CRVL sits 32% above its 52-week low of $44.83.
Summary
CorVel's Q1 FY2027 results show accelerating growth and profitability, backed by a debt-free balance sheet with over a quarter-billion in cash. The company continues to buy back stock aggressively.
Key Events · Earnings and Guidance · CRVL
-
Revenue Climbs 11% to $260M
Driven by growth across Patient Management and Network Solutions, Q1 FY2027 revenue reached $260 million, up from $235 million in the prior-year quarter.
-
EPS Jumps 21% to $0.63
Reflecting improved operating leverage and a lower share count from buybacks, diluted earnings per share rose to $0.63 from $0.52.
-
Gross Margin Expands to 26%
Gross profit increased 19% to $67.8 million, with gross margin improving from 24% to 26%, indicating better cost management and mix.
-
Cash Hoard Grows to $256M, Debt-Free
The quarter ended with $255.9 million in cash and equivalents, no borrowings, and total assets of $689.7 million.
Analysis · CRVL · Finance
A strong start to fiscal 2027 saw CorVel deliver double-digit revenue and earnings growth, expanding margins, and a fortress balance sheet. The 11% revenue increase and 21% EPS jump signal continued momentum in its core workers' compensation and liability markets. With $256 million in cash and zero borrowings, the company has ample firepower for further buybacks or strategic investments. The $21.8 million in quarterly repurchases underscores management's commitment to returning capital, though the recent insider selling pattern warrants monitoring.
How filings like this one have moved
In the 30 days to Oct 4, 2026, 29.1% of the 1575 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.60%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CRVL was trading at $59.10 on NASDAQ in the Finance sector, with a market capitalization of approximately $3B. The 52-week trading range was $44.83 to $93.71. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.